| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 962,266 | 979,257 | 992,100 | 1,078,707 | | Cost of Revenue | 426,433 | 439,836 | 447,729 | 502,399 | | | Gross Profit | 535,833 | 539,421 | 544,371 | 576,308 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 367,892 | 375,113 | 372,324 | 391,071 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 58,124 | 56,399 | 57,541 | 54,741 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 109,817 | 107,909 | 114,506 | 130,496 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,753) | (410) | 1,139 | (3,771) | | Earnings Before Interest And Taxes | 71,354 | 107,499 | 115,645 | 126,725 | | Interest Expense | (18,367) | 18,367 | 22,749 | 23,266 | | Income Before Tax | 89,721 | 89,132 | 92,896 | 103,459 | | Income Tax Expense | 35,181 | 34,316 | 36,415 | 40,556 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 52,529 | 54,816 | 56,481 | 62,903 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 54,540 | 54,816 | 56,481 | 62,903 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $54,540 | $54,816 | $56,481 | $62,903 |
|
0.11% Nasdaq 0.00%
Income Statement
